$86.08
+1.45 (+1.71%)
Performance
1D
—
1W
—
1M
—
3M
+8.93%
6M
+40.52%
1Y
+186.27%
YTD
+18.31%
Open$84.81
Previous Close$84.63
Day High$86.90
Day Low$83.65
52W High$103.00
52W Low$28.06
Volume—
Avg Volume560.0K
Market Cap6.96B
P/E Ratio—
EPS$-3.57
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.66
Above
SMA 200
$56.03
Above
RSI (14)
77.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
29 analysts
Price Target
-64.0% upside
Current
$86.08
$86.08
Target
$31.03
$31.03
$20.33
$31.03 avg
$33.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.53M | 39.82M | 7.83B |
| Net Income | -298,013,223 | -284,574,960 | 335.40M |
| Profit Margin | -794.0% | -754.3% | 4.3% |
| EBITDA | -326,480,158 | -329,078,143 | 592.59M |
| Free Cash Flow | — | — | 369.62M |
| Rev Growth | -5.8% | -5.8% | +18.7% |
| Debt/Equity | 0.00 | 0.00 | 0.53 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |